荣昌生物（09995）今日盘中大涨6.32%，领涨港股生物医药板块。该板块整体表现强劲，药明巨诺-B、百奥赛图-B等多只个股均有不同程度上涨。
消息面上，荣昌生物官方微博宣布，公司将在即将召开的2025年欧洲肿瘤内科学会（ESMO）年会上发布11项原创研究成果。其中，维迪西妥单抗联合治疗一线尿路上皮癌的RC48-C016Ⅲ期临床研究被选为"最新突破摘要"（Late-Breaking Abstracts，LBA），彰显了该研究的重要学术价值。
ESMO年会是全球最具影响力的肿瘤学术会议之一，将于10月17日至21日在德国柏林举行。荣昌生物此次将通过2项简短口头报告和8项壁报展示，全面呈现其在尿路上皮癌、胃癌、妇科肿瘤等领域的最新研究进展。这些研究成果的公布，不仅展示了公司在ADC药物联合治疗方面的领先实力，也进一步增强了投资者对公司未来发展前景的信心。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.